Haleon plc
$9.24
$0.14(-1.49%)
Haleon plc
HLN
$9.24
$0.14(-1.49%)
Haleon plc
HLN
NYSE
$9.24
$0.14(-1.49%)
Chart
Upcoming Earnings
Next report date
Jul 30, 2026
Report period
Q3 2026
EPS Estimate
$0.28
Revenue Estimate
$7.59B
Key stats
52-Week Range$9.24
$8.71
$11.42
Market capitalization
$40.76BDividend yield (indicated)
2.06%Price to earnings Ratio (TTM)
30.05Basic EPS (TTM)
$0.62Net income (TTM)
$2.78BRevenue (TTM)
$19.27BAvg. volume
8.17MBeta (1Y)
0.33Employees
24.56KMarket capitalization
$40.76BDividend yield (indicated)
2.06%Price to earnings Ratio (TTM)
30.05Basic EPS (TTM)
$0.62Net income (TTM)
$2.78BRevenue (TTM)
$19.27BAvg. volume
8.17MBeta (1Y)
0.33Employees
24.56KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Haleon plc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Brian James McNamara
Website
www.haleon.comHeadquarters
Building 5, Weybridge, KT13 0NY
IPO Date
2022-07-25
Identifiers
ISIN
US4055521003Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products...
Related Stocks
$16.55
1D:
-0.1%
1Y:
7.6%
US8740602052Healthcare
Mkt Cap
$52.28B
P/E Ratio TTM
73.3
Revenue TTM
$4.49T
Beta
0.13
Earnings TTM
$114.75B
Dividend Yield TTM
3.82%
$144.17
1D:
-1.5%
1Y:
39.7%
US0758871091Healthcare
Mkt Cap
$52.23B
P/E Ratio TTM
24.2
Revenue TTM
$21.92B
Beta
0.35
Earnings TTM
$1.76B
Dividend Yield TTM
2.50%
Dividend Overview
Dividend yield (indicated)
2.06%
Dividend per share
$0.07annual
Payout ratio (Earnings)
40.0%
Payout ratio (FCF)
69.1%
Dividend growth streak
0
Dividend CAGR (3Y)
+8.0%
Dividend CAGR (5Y)
—
Dividend CAGR (10Y)
—
Dividend yield (indicated)
2.06%
Dividend per share
$0.07annual
Payout ratio (Earnings)
40.0%
Payout ratio (FCF)
69.1%
Dividend growth streak
0
Dividend CAGR (3Y)
+8.0%
Dividend CAGR (5Y)
—
Dividend CAGR (10Y)
—
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate